250 related articles for article (PubMed ID: 11273166)
1. Impaired fasting glucose (IFG) versus impaired glucose tolerance (IGT): the present scenario.
Kundu AK
J Assoc Physicians India; 2000 May; 48(5):551-2. PubMed ID: 11273166
[No Abstract] [Full Text] [Related]
2. [Borderline type, impaired glucose tolerance (IGT), and impaired fasting glucose (IFG): their concepts, classification and significance].
Kuzuya T
Nihon Rinsho; 2005 Feb; 63 Suppl 2():15-20. PubMed ID: 15779339
[No Abstract] [Full Text] [Related]
3. Fasting cut-offs in determining the prevalence of diabetes and intermediate glucose abnormality in a non-obese population.
Sayeed MA; Mahtab H; Khanam PA; Keramat Ali SM; Chowdhury RI; Vaaler S; Hussain A; Azad Khan AK
Bangladesh Med Res Counc Bull; 2004 Dec; 30(3):105-14. PubMed ID: 16240981
[TBL] [Abstract][Full Text] [Related]
4. [Impact of lowering the cut-point for impaired fasting glucose on the distribution of impaired glucose regulation subcategories in Chinese adult population].
Yang ZJ; Yang WY; Xiao JZ; Li GW; Wang Y
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1773-6. PubMed ID: 15631770
[TBL] [Abstract][Full Text] [Related]
5. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
[TBL] [Abstract][Full Text] [Related]
6. Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies.
Gerstein HC; Santaguida P; Raina P; Morrison KM; Balion C; Hunt D; Yazdi H; Booker L
Diabetes Res Clin Pract; 2007 Dec; 78(3):305-12. PubMed ID: 17601626
[TBL] [Abstract][Full Text] [Related]
7. Comparison of The World Health Organization (WHO) two-step strategy and OGTT for diabetes mellitus screening.
Adam JM; Tarigan NP
Acta Med Indones; 2004; 36(1):3-7. PubMed ID: 15931695
[TBL] [Abstract][Full Text] [Related]
8. How to minimize missing those subjects with high 2HR plasma glucose but 'normal' fasting plasma glucose levels?
Ko GT; Cockram CS; Chan JC
J Med; 2001; 32(1-2):53-65. PubMed ID: 11321888
[TBL] [Abstract][Full Text] [Related]
9. Diabetes screening after gestational diabetes mellitus: poor performance of fasting plasma glucose.
Cypryk K; Czupryniak L; Wilczyński J; Lewiński A
Acta Diabetol; 2004 Mar; 41(1):5-8. PubMed ID: 15057547
[TBL] [Abstract][Full Text] [Related]
10. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
[TBL] [Abstract][Full Text] [Related]
11. [Fasting glucose versus oral glucose tolerance testing in the diagnosis of diabetes mellitus].
Mollar-Puchades MA; Pallarés-Carratalá V; Navas de Solís MS; Piñón-Sellés F
Rev Esp Cardiol; 2006 Dec; 59(12):1349-50. PubMed ID: 17194436
[No Abstract] [Full Text] [Related]
12. The burden of diabetes and impaired fasting glucose in India using the ADA 1997 criteria: prevalence of diabetes in India study (PODIS).
Sadikot SM; Nigam A; Das S; Bajaj S; Zargar AH; Prasannakumar KM; Sosale A; Munichoodappa C; Seshiah V; Singh SK; Jamal A; Sai K; Sadasivrao Y; Murthy SS; Hazra DK; Jain S; Mukherjee S; Bandyopadhay S; Sinha NK; Mishra R; Dora M; Jena B; Patra P; Goenka K;
Diabetes Res Clin Pract; 2004 Dec; 66(3):293-300. PubMed ID: 15536027
[TBL] [Abstract][Full Text] [Related]
13. [IFG and IGT in Europe and America: the present and prospective].
Tsujii S; Kuzuya H
Nihon Rinsho; 2005 Feb; 63 Suppl 2():27-33. PubMed ID: 15779341
[No Abstract] [Full Text] [Related]
14. [The distributive characteristics of impaired glucose metabolism subcategories in Chinese adult population].
Yang ZJ; Yang WY; Li GW;
Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(24):2128-31. PubMed ID: 14720420
[TBL] [Abstract][Full Text] [Related]
15. Glucose and cardiovascular risk.
Fuchs M; Hoekstra JB; Mudde AH
Neth J Med; 2002 Jun; 60(5):192-9. PubMed ID: 12365474
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of impaired fasting glycemia, impaired glucose tolerance, and type 2 diabetes in hemodialyzed patients when applying new diagnostic criteria.
Elbert A; Schreier L; Galli C; Beresan H; Lopez G; Traversa M; Berg G
J Ren Nutr; 2006 Oct; 16(4):300-3. PubMed ID: 17046613
[TBL] [Abstract][Full Text] [Related]
17. Increasing incidence of abnormal glucose tolerance in women with prior abnormal glucose tolerance during pregnancy: DIAGEST 2 study.
Vambergue A; Dognin C; Boulogne A; Réjou MC; Biausque S; Fontaine P
Diabet Med; 2008 Jan; 25(1):58-64. PubMed ID: 18028442
[TBL] [Abstract][Full Text] [Related]
18. Impaired fasting glucose vs. glucose intolerance in pre-menopausal women: distinct metabolic entities and cardiovascular disease risk?
Piché ME; Després JP; Pascot A; Nadeau A; Tremblay A; Weisnagel SJ; Bergeron J; Lemieux S
Diabet Med; 2004 Jul; 21(7):730-7. PubMed ID: 15209766
[TBL] [Abstract][Full Text] [Related]
19. Effect of lower diagnostic thresholds on estimates of prevalence of impaired fasting glucose (IFG).
Mannucci E; Bardini G; Rotella CM
Diabet Med; 2005 Mar; 22(3):353-4. PubMed ID: 15717889
[No Abstract] [Full Text] [Related]
20. Distribution of fasting plasma glucose and prevalence of impaired fasting glucose, impaired glucose tolerance and type 2 diabetes in the Mexican paediatric population.
Guerrero-Romero F; Violante R; Rodríguez-Morán M
Paediatr Perinat Epidemiol; 2009 Jul; 23(4):363-9. PubMed ID: 19523083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
